Brad Alan Yentzer, MD Resume


2020 - Present

2017 - 2020

2013 - 2017

Finger Lakes Dermatology, Dryden NY
*Founder and CEO

Cayuga Medical Associates, Ithaca NY

The Corvallis Clinic, Corvallis OR



American Board of Dermatology Certified

New York Unrestricted Medical License


2010 - 2013

2007 - 2010

2006 - 2007

2002 - 2006

1997 - 2001

Resident, Dermatology
Wake Forest Baptist Health, Winston-Salem, NC

Senior Clinical Research Fellow
Center For Dermatology Research, Wake Forest Baptist Health, Winston Salem, NC

Transitional Year Residency Program     
Mercy Catholic Medical Center, Darby, PA

Medical Doctorate
Jefferson Medical College, Philadelphia, PA

Bachelor of Arts in Biology
LaSalle University, Philadelphia, PA            










DermMentors Resident of Distinction Award

American Acne and Rosacea Society Research Grant Recipient

Chief Resident – Transitional Residency Program

Dermatology abroad - Brisbane, Australia 

American Medical Student Association – Jefferson Committee Member

Jefferson Students for Dermatology – Member / Organizer

Jefferson Free Online Study Aid – Question writer

Graduated Magnum Cum Laude Phi Alpha Beta (LaSalle Biology Club) – President
LaSalle Environmental Workshop & Green Campus Day
Dean’s list

Research Experience

2014 -2016

2007 - 2010 


2001 - 2002


1999 & 2000

The Corvallis Clinic   Corvallis, OR
 -Dr. Yentzer worked on several Phase III clinical trials for psoriasis treatments, including Humira, Stelara and Cosentyx.

Wake Forest University Baptist Medical Center
  Winston Salem, NC
 -Working for the Center for Dermatology Research, Dr. Yentzer conducted health services and health outcomes research. His work focused on adherence to dermatologic treatments, the relationship between efficacy of therapy and adherence, and interventions to increase adherence to treatment regimens.

Thomas Jefferson University
  Philadelphia, PA
  -Dr. Yentzer pioneered using zebrafish as a model for studying inhibitors of the Epidermal Growth Factor Receptor (EGFR) under direction of Dr. Ulrich Rodeck.  

Medical Research Institute for Chemical Defense (USAMRID)
      Aberdeen, MD
  -Working with Dr. John Schlager, Dr. Yentzer used molecular subtraction libraries to study gene regulation in keratinocytes after exposure to the chemical warfare agents sulfur mustard and VX gas. 

Wistar Institute  Philadelphia, PA
 -Working in Dr. Meenhard Herlyn’s lab, Dr. Yentzer examined the potential relationship between the regulation of angiogenesis and invasive characteristics of melanoma.  

Veterans Affairs Medical Center
 Coatesville, PA
  -Working with Dr. Greg Golden, Dr. Yentzer helped conduct molecular genetic studies of cocaine-kindled seizures and anticonvulsant drugs.